Until recently, Dr. Stephen G. Waxman, director of the Yale University-affiliated Center for Neuroscience and Regeneration Research, refused to use the c-word. Repairing severed spinal cords, treating multiple sclerosis or relieving the intense pain that lingers after an amputation were Continue reading ‘Cure’ no longer wrong word in paralysis research
A revolutionary treatment could provide the solution to many life-threatening, inherited diseases Push to the back of your mind all the recent research identifying genes associated with disease. This landmark research is about actually re-writing genes. It opens up the Continue reading Fixing genes is a snip
A Decade of Dedication Dr. Zarife Sahenk of Ohio State University will speak on Advances in Nerve Regeneration at the The Second National Neuropathy Association Conference next month.
As you know, our Congressional champions are re-introducing the Christopher Reeve Paralysis Act at the Spring Into Action Rally tomorrow, April 12th, in Washington D.C. Over 150 advocates are attending to educate legislators from across the country on paralysis research Continue reading Spring into Action! Join by phone
Neurobiol Dis. 2005 Apr;18(3):656-68. Giambonini-Brugnoli G, Buchstaller J, Sommer L, Suter U, Mantei N. Point mutations affecting PMP22 can cause hereditary demyelinating and dysmyelinating peripheral neuropathies. In addition, duplication and deletion of PMP22 are associated with Charcot-Marie-Tooth disease Type 1A Continue reading Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation
A message from the Christopher Reeve Action Network We knew that our opponents were gearing up for an assault on research, and here they come. Senators Sam Brownback (R-KS) and Mary Landrieu (D-LA) and Representative Dave Weldon (R-FL) have introduced Continue reading The Fight is On. Protect Research, Defend Hope!
Another article on the BrainGate system from Cyberkinetics: The development means scientists might one day be able to connect the brains of paralyzed patients to muscle stimulators, allowing them to once again move their paralyzed limbs. Donoghue envisions a time Continue reading Scientist envisions electronic solution to damaged nervous systems
The American Society for Neurochemistry will be holding its 36th annual meeting from June 24 through 29 in Madison, Wisconsin. The program includes at least one lecture of interest, on Molecules and Mechanisms in Schwann Cell Development.
Curis, Inc. (NASDAQ: CRIS), a therapeutic drug development company, today announced that it has achieved a development milestone under a collaboration with one of its corporate partners, Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE). The milestone is based on Continue reading Curis Achieves Milestone under Wyeth Collaboration
A new treatment that uses two old drugs together may offer hope of relief to millions of North Americans who suffer neuropathic pain. A type of chronic stabbing, burning pain, neuropathic pain is often a mystery to health care workers. Continue reading New treatment offers better neuropathic pain relief: study